The results of this week’s poll about site-neutral payment extensions.
The results are in for our first-ever MHE Question of the Week
Our readers were 63% in favor and 37% against site-neutral payment rules and policies being extended to commercial payers, payment for physician-administered drugs, and services delivered in on-campus, hospital, and outpatient departments. We posed the question on Tuesday and collected answers through today at 4 p.m.
Site-neutral payment rules have been a hotly debated topic, setting payers and hospitals at odds.
A study done in February 2023 found that expanding the site-neutral payment system would save the government and patients $471 billion over 10 years.
However, the American Hospital Association (AHA) opposes site-neutral payment, arguing that the extra fees are appropriate for the level of care provided in different locations.
Tune in next week for another MHE Question of the Week!
We want to know what you’re thinking! Every Tuesday morning at 10 a.m. E.T. the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We'll tally your answers and publish the results on Friday by 5 p.m. ET.
Most Real-World Studies Report Positive Outcomes of Rituximab Use in Multiple Sclerosis
May 8th 2024Although several clinical trials have confirmed the safety and efficacy of rituximab in oncology and autoimmune disease, and even as off-label use in MS, real-world evidence is still necessary to help guide clinicians and managed care professionals in their treatment and coverage decision-making.
Read More